These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 8030046)

  • 1. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
    [No Abstract]   [Full Text] [Related]  

  • 2. Indefinite survival following small intestinal transplantation after intrathymic injection of the donor with recipient-type splenocytes in a rat model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplantation; 1995 Jan; 59(2):309-11. PubMed ID: 7839457
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
    Xia W; Sayegh MH; Kirkman RL
    Transplant Proc; 1994 Jun; 26(3):1581. PubMed ID: 8030045
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged small bowel allograft survival following repeated intrathymic injections of donor splenocytes and peripheral anti-lymphocyte treatment.
    Sun S; Greenstein SM; Schechner RS; Tellis VA
    Transplant Proc; 1999; 31(1-2):588-9. PubMed ID: 10083249
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of intrathymic injection of donor splenocytes on rat small bowel allograft survival.
    Karim MS; Webster GA; Wood RF; Pockley AG
    Transplant Proc; 1994 Jun; 26(3):1583-4. PubMed ID: 8030047
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance for graft-versus-host disease by intrathymic injection of recipient-type splenocytes into donor.
    Vaidya S; Wang CC; Roorda C; Billings A; Rajaraman S; Fish JC
    Transplant Proc; 1997; 29(1-2):1073-5. PubMed ID: 9123205
    [No Abstract]   [Full Text] [Related]  

  • 7. Amelioration of graft-versus-host disease following bowel transplantation with recipient specific leukocyte transfusion.
    Xiao F; Foster PF; Sankary HN; Kociss K; Williams JW
    Transplant Proc; 1992 Jun; 24(3):1192-3. PubMed ID: 1604582
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of small bowel allografts after intrathymic injection of donor alloantigen and ALS.
    Goss JA; Nakafusa Y; Flye MW
    J Surg Res; 1993 May; 54(5):494-8. PubMed ID: 8361174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation.
    He G; Wang M; Xu H; Tian L; Yu J; Stepkowski SM; Kahan BD
    Transplant Proc; 1996 Oct; 28(5):2469. PubMed ID: 8907906
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of simultaneous intrathymic injection of two unrelated cellular alloantigens on rat cardiac allograft survival.
    Shimomura K; Hardy MA; Oluwole SF
    Transplant Proc; 1995 Feb; 27(1):127. PubMed ID: 7878878
    [No Abstract]   [Full Text] [Related]  

  • 11. Generation of suppressor cells maintains donor-specific tolerance after intrathymic injection of alloantigen.
    Nakafusa Y; Arima T; Goss JA; Flye MW
    Transplant Proc; 1995 Feb; 27(1):128-9. PubMed ID: 7878881
    [No Abstract]   [Full Text] [Related]  

  • 12. Pretreatment with irradiation and donor-specific transfusion prolongs survival in small intestinal transplantation.
    Greenstein SM; Sun SC; Senitzer D; Schechner RS; Tellis VA
    Transplant Proc; 1993 Feb; 25(1 Pt 1):490-1. PubMed ID: 8438391
    [No Abstract]   [Full Text] [Related]  

  • 13. Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.
    Langrehr JM; Markus PM; Lee TK; Müller AR; Banner B; Lee KK; Schraut WH
    Transplant Proc; 1992 Jun; 24(3):1138. PubMed ID: 1604556
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
    Greenstein SM; Sun S; Schechner RS; Tellis VA
    Transplant Proc; 1997; 29(1-2):1065-6. PubMed ID: 9123201
    [No Abstract]   [Full Text] [Related]  

  • 15. Mesenteric and intraepithelial lymphocytes are insufficient to cause rejection but able to mediate lethal graft-versus-host disease in small bowel transplants.
    Xia W; Brandeis JM; Sayegh M; Kirkman RL
    Transplant Proc; 1994 Jun; 26(3):1508-9. PubMed ID: 8030013
    [No Abstract]   [Full Text] [Related]  

  • 16. Allograft ultraviolet-B irradiation in rat small intestinal transplantation.
    Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1624-5. PubMed ID: 8030062
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
    Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
    Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
    [No Abstract]   [Full Text] [Related]  

  • 18. Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.
    Fecteau A; Tchervenkov J; Guttman FM; Rosenmann E
    Transplant Proc; 1992 Jun; 24(3):1166. PubMed ID: 1604571
    [No Abstract]   [Full Text] [Related]  

  • 19. A second intrathymic injection of donor splenocytes improves survival of small bowel allografts.
    Sun S; Greenstein SM; Kim DY; Schreiber TC; Schechner RS; Tellis VA
    Transplant Proc; 1998 Sep; 30(6):2575-6. PubMed ID: 9745495
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
    Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
    J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.